Investigation of New Agents in Small-Cell Lung Cancer
- 1 April 1993
- Vol. 103 (4) , 423S-426S
- https://doi.org/10.1378/chest.103.4_supplement.423s
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Justification for Evaluating New Anticancer Drugs in Selected Untreated Patients With Extensive-Stage Small-Cell Lung Cancer: An Eastern Cooperative Oncology Group Randomized StudyJNCI Journal of the National Cancer Institute, 1992
- Single-agent chemotherapy trials in small-cell lung cancer, 1970 to 1990: the case for studies in previously treated patients.Journal of Clinical Oncology, 1992
- Teniposide and etoposide in previously untreated small-cell lung cancer: a randomized study.Journal of Clinical Oncology, 1991
- Small cell carcinoma of the lung: clinical and biologic aspectsCritical Reviews in Oncology/Hematology, 1991
- Current status of etoposide in the management of small cell lung cancerCancer, 1991
- Phase II study of amonafide: results of treatment and lessons learned from the study of an investigational agent in previously untreated patients with extensive small-cell lung cancer.Journal of Clinical Oncology, 1990
- New drugs in the management of small cell lung cancerLung Cancer, 1989
- The design of phase II trialsLung Cancer, 1989
- Small cell carcinoma of the lungCritical Reviews in Oncology/Hematology, 1986
- The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agentJournal of Chronic Diseases, 1961